MedTrace Logo

Plasma RBP Levels in Patients With Idiopathic Hypogonadotrophic Hypogonadism

NCT01758094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2013-01-03

No results posted yet for this study

Summary

The aim of the present study was to demonstrate the RBP4 levels, association of RBP4 with insulin resistance and influence of testosterone treatment on this cytokine in patients with idiopathic hypogonadotropic hypogonadism.

Conditions

  • Idiopathic Hypogonadotropic Hypogonadism

Interventions

DRUG

Sustanon 250 mg ampule (Testosterone esters)

Drug used for treatment of hypogonadism

Sponsors & Collaborators

  • Gulhane School of Medicine

    lead OTHER

Principal Investigators

  • Aydogan Aydogdu, MD · Gulhane School of Medicine, Department of Endocrinology and Metabolism

Eligibility

Min Age
19 Years
Max Age
26 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-08-31
Completion
2012-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01758094 on ClinicalTrials.gov